🚨 ALERT: $ATYR Shares Structurally Locked Up — Coiled Spring Setup 🚨

aTyr Pharma ($ATYR) is now showing one of the most tightly locked-up float structures in biotech. Based on a full aggregation of 13F, 13G, and NPORT filings, over 83.4M shares are institutionally held, out of an ~86M float — meaning 95%+ of float is already spoken for. Key holders include Federated Hermes, FMR (Fidelity), Vanguard (across multiple vehicles), Point72, Tikvah, Adage, FBIOX, & Logos, with almost no selling pressure and many funds increasing exposure.

At the same time, short interest is over 12.2% of float with 9.5 days to cover, creating a textbook illiquidity trap. Retail participation remains minimal. Passive index funds have yet to fully buy in, & the Phase 3 readout catalyst still lies ahead, and soon. Structurally, this is a coiled spring: when the next wave of demand arrives — whether through retail FOMO, index inflows, or post-readout institutions — there simply won’t be enough supply.

https://fintel.io/so/us/atyr